Top

Published in:

01-08-2012 | Review article

Depression as a risk factor for breast cancer: investigating methodological limitations in the literature

Published in: Cancer Causes & Control | Issue 8/2012

Abstract

Purpose

A relationship between depression and the development of breast cancer has not been convincingly shown in the research conducted over the past three decades.

Methods

In an effort to better understand the conflicting results, a review was conducted focusing on the methodological problems associated with this literature, including time frame between the assessment of depression and the diagnosis of breast cancer and the use of somatic items in measuring depression. Fifteen breast cancer prospective studies were reviewed.

Results

While twelve of the studies found positive associations between depression and breast cancer development, three studies found negative associations. With regard to the predictive associations between depression and breast cancer incidence, the findings revealed that (a) studies using a longer time frame found a stronger association than studies using a shorter time frame and (b) studies utilizing depression measures that did not contain somatic items found a smaller association than studies utilizing depression measures that did contain these items.

Conclusions

Future studies should ensure that sufficient periods of time between the measurement of depression and the assessment of cancer and avoid measuring depression using somatic items.

It should be noted that Gross et al.’s [49] publication is an update of Gallo et al. [47] including an additional wave of data collection, which extends the time frame from 13 to 24 years. In addition, both studies use only partially identical methodological control variables.

American Cancer Society. Cancer Facts & Figures 2010. Available from URL: http://www.cancer.org/acs/groups/content/@epidemiologysurveilance/documents/document/acspc-026238.pdf. Accessed 5 Sep 2011

Greer S (1983) Cancer and the mind. Br J Psychiatry 14:535–543CrossRef

Snow HL (1893) Cancer and the cancer process. Churchill, London

Ader R, Cohen N, Felten D (1995) Psychoneuroimmunology: interaction between the nervous system and the immune system. Lancet 345:99–103PubMedCrossRef

Andersen BL, Farrar WB, Golden-Kreutz D et al (1998) Stress and immune responses after surgical treatment for regional breast cancer. J Natl Cancer Inst 90:30–36PubMedCrossRef

Schleifer SJ, Keller SE, Bartlett JA, Eckholdt HM, Delaney BR (1996) Immunity in young adults with major depressive disorder. Am J Psychiatry 153:477–482PubMed

Kiecolt-Glaser JK, Robles TF, Heffner KL, Loving TJ, Glaser R (2002) Psycho-oncology and cancer: psychoneuroimmunology and cancer. Ann Oncol 13:165–169PubMedCrossRef

Glaser R, Thorn BE, Tarr KL, Kiecolt-Glaser JK, D’Ambrosio SM (1985) Effects of stress on methyltransfease synthesis: an important DNA repair enzyme. Br J Health Psychol 4:403–412CrossRef

Pulaski L, Kania K, Ratajewski M et al (2005) Differential regulation of the human MRP2 and MRP3 gene expression by glucocorticoids. J Steroid Biochem Mol Biol 2005(96):229–234CrossRef

10.

Su F, Ouyang N, Zhu P et al (2005) Psychological stress induces chemoresistance in breast cancer by upregulating mdr1. Biochem Biophys Res Commun 329:888–897PubMedCrossRef

11.

Ticher A, Haus E, Ron IG et al (1996) The pattern of hormonal circadian time structure (acrophase) as an assessor of breast cancer risk. Int J Cancer 65:591–593PubMedCrossRef

12.

Butow PN, Hiller JE, Price MA, Thackway SV, Kricker A, Tennant CC (2000) Epidemiological evidence for a relationship between life events, coping style, and personality factors in the development of breast cancer. J Psychosom Res 49:169–181PubMedCrossRef

13.

Dalton SO, Boesen EH, Ross L, Schapiro IR, Johansen C (2002) Mind and cancer: do psychological factors cause cancer? Eur J Cancer 38:1313–1323PubMedCrossRef

14.

Garssen B (2004) Psychological factors and cancer development: evidence after 30 years of research. Clin Psychol Rev 24:315–338PubMedCrossRef

15.

McGee R, Williams S, Elwood M (1994) Depression and the development of cancer: a meta-analysis. Soc Sci Med 38:187–192PubMedCrossRef

16.

McKenna MC, Zevon MA, Corn B, Rounds J (1999) Psychosocial factors and the development of breast cancer: a meta-analysis. Health Psychol 18:520–531PubMedCrossRef

17.

Oerleman MEJ, van den Akker M, Schuurman AG, Kellen E, Buntinx F (2007) A meta-analysis on depression and subsequent cancer risk. Clin Pract Epidemiol Mental Health 3:29CrossRef

18.

Spiegel D, Giese-Davis J (2003) Depression and cancer: mechanisms and disease progression. Biol Psychiatry 54:269–282PubMedCrossRef

19.

Friberg S, Mattson S (1997) On the growth rates of human malignant tumors: implications for medical decision making. J Surg Oncol 65:284–297PubMedCrossRef

20.

Spratt JS, Meyer JS, Spratt JA (1996) Rates of growth of human solid neoplasms: part II. J Surg Oncol 61:68–83PubMedCrossRef

21.

Eskelinen M, Ollonen P (2011) Beck Depression Inventory in patients with breast disease and breast cancer: a prospective case–control study. In Vivo 25:111–116PubMed

22.

Eskelinen M, Ollonen P (2011) Montgomery-Asberg Depression Rating Scale (MADRS) in healthy study subjects, in patients with breast disease and breast cancer: a prospective case–control study. Anticancer Res 31:1065–1069PubMed

23.

24.

Eskelinen M, Ollonen P (2011) Measurement of pessimism: Hopelessness Scale in healthy study subjects, in patients with breast disease and breast cancer: a prospective case–control study in Finland. Anticancer Res 31:4019–4023PubMed

25.

Ollonen P, Lehtonen J, Eskelinen M (2005) Anxiety, depression and the history of psychiatric symptoms in patients with breast disease: a prospective case–control study in Kuopio, Finland. Anticancer Res 25:2527–2534PubMed

26.

Dugan W, McDonald MV, Passik SD, Rosenfeld BD, Theobald D, Edgerton S (1998) Use of the Zung Self-Rating Depression Scale in cancer patients: feasibility as a screening tool. Psycho-Oncology 7:483–493PubMedCrossRef

27.

Wedding U, Koch A, Röhrig B et al (2007) Requestioning depression in patients with cancer: contribution of somatic and affective symptoms to Beck’s Depression Inventory. Ann Oncol 18:1875–1881PubMedCrossRef

28.

Endicott J (1984) Measurement of depression in patients with cancer. Cancer 53:2243–2248PubMed

29.

Cavaugh S (1984) Diagnosing depression in the hospitalised patient with chronic medical illness. J Clin Psychiatry 45:13–16

30.

Ryder AG, Yang J, Zhu X, Yao S, Yi J, Heine SJ, Bagby RM (2008) The cultural shaping of depression: somatic symptoms in China, psychological symptoms in North America? J Abnorm Psychol 117:300–313PubMedCrossRef

31.

American Psychiatric Association (1994) Diagnostic and Statistical Manual of Mental Disorders (DSM-IV), 4th edn. American Psychiatric Association, Washington, DC

32.

Akechi T, Nakano T, Akizuki N et al (2003) Somatic symptoms for diagnosing major depression in cancer patients. Psychosomatics 44:244–248PubMedCrossRef

33.

Bleiker EM, Hendriks JH, Otten JD, Verbeek AL, van der Ploeg HM (2008) Personality factors and breast cancer risk: a 13-year follow-up. J Natl Cancer Inst 100:213–218PubMedCrossRef

34.

Bushman BJ, Wang MC (2009) Vote-counting procedures in meta-analysis. In: Cooper H, Hedges LV, Valentine JC (eds) The handbook of research synthesis and meta-analysis, 2nd edn. Russell Sage Foundation, New York, pp 207–220

35.

Aro AR, de Koning HJ, Schreck M, Hendriksson M, Anttila A, Pukkala E (2005) Psychological risk factors of incidence of breast cancer: a prospective cohort study in Finland. Psychol Med 35:1515–1521PubMedCrossRef

36.

Bleiker EMA, van der Ploeg JHCL, Hendriks HJA (1996) Personality factors and breast cancer development: a prospective longitudinal study. J Natl Cancer Inst 88:1478–1482PubMedCrossRef

37.

Penninx BW, Guralnik JM, Pahor M et al (1998) Chronically depressed mood and cancer risk in older persons. J Natl Cancer Inst 90:1888–1893PubMedCrossRef

38.

Goldacre MJ, Wotton CJ, Yeates D, Seagroatt V, Flint J (2007) Cancer in people with depression and anxiety: record-linkage study. Soc Psychiatry Epidemiol 42:683–689CrossRef

39.

Nykliček I, Louwman WJ, Van Nierop PW, Wijnands CJ, Coebergh JW, Pop VJ (2003) Depression and the lower risk for breast cancer development in middle-aged women: a prospective study. Psychol Med 33:1111–1117PubMedCrossRef

40.

Gallo JJ, Armenian HK, Ford DE, Eaton WW, Khachaturian AS (2000) Major depression and cancer: the 13-year follow-up of the Baltimore epidemiologic catchment area sample (United States). Cancer Causes Control 11:751–758PubMedCrossRef

41.

Gross AL, Gallo JJ, Eaton WW (2010) Depression and cancer risk: 24 years of follow-up of the Baltimore epidemiologic catchment area sample. Cancer Causes Control 21:191–199PubMedCrossRef

42.

Jacobs JR, Bovasso GB (2000) Early and chronic stress and their relation to breast cancer. Psychol Med 30:669–678PubMedCrossRef

43.

Lichtman JH (1996) Are depressive symptoms, social networks and social support, or self-evaluated health measures predictive of cancer incidence and stage of diagnosis? Evidence from a prospective community based sample of elderly New Haven residents (Doctoral dissertation). Yale University, New Haven

44.

Hahn RC, Petitti DB (1988) Minnesota Multiphasic Personality Inventory-rated depression and the incidence of breast cancer. Cancer 61:845–848PubMedCrossRef

45.

Hjerl K, Andersen EW, Keiding N et al (1999) Breast cancer risk among women with psychiatric admission with affective or neurotic disorders: a nationwide cohort study in Denmark. Br J Cancer 81:907–911PubMedCrossRef

46.

Dalton SO, Mellemkjaer L, Olsen JH, Mortensen PB, Johansen C (2002) Depression and cancer risk: a register-based study of patients hospitalized with affective disorders, Denmark, 1969–1993. Am J Epidemiol 155:1088–1095PubMedCrossRef

47.

Kaplan GA, Reynolds P (1988) Depression and cancer mortality and morbidity: prospective evidence from the Alameda County study. J Behav Med 11:1–13PubMedCrossRef

48.

Knekt P, Raitasalo R, Heliövaara M et al (1996) Elevated lung cancer risk among persons with depressed mood. Am J Epidemiol 144:1096–1103PubMedCrossRef

49.

Chen Y-H, Lin H-C (2011) Increased risk of cancer subsequent to severe depression-A nationwide population-based study. J Affect Disord 131:200–206PubMedCrossRef

50.

Liang J-A, Sun L-M, Muo C-H et al (2011) The analysis of depression and subsequent cancer risk in Taiwan. Cancer Epidemiol Biomark Prev 20:473–475CrossRef

51.

Schuurman AG, van den Akker M, Ensinck KTJL et al (2001) Does depression increase susceptibility for somatic disease? NWO-report. Research Institute Ex Tra, Maastricht

52.

Kuehner C, Holzhauer S, Huffziger S (2007) Decreased cortisol response to awakening is associated with cognitive vulnerability to depression in a nonclinical sample of young adults. Psychoneuroendocrinology 32:199–209PubMedCrossRef

53.

Nolen-Hoeksema S, Morrow J (1991) A prospective study of depression and posttraumatic stress symptoms after a natural disaster: the 1989 Loma Prieta earthquake. J Pers Soc Psychol 61:115–121PubMedCrossRef

Title: Depression as a risk factor for breast cancer: investigating methodological limitations in the literature
Publication date: 01-08-2012
Published in: Cancer Causes & Control / Issue 8/2012
Print ISSN: 0957-5243
Electronic ISSN: 1573-7225
DOI: https://doi.org/10.1007/s10552-012-0014-y

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Purpose

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 8/2012

Gastrectomy and risk of pancreatic cancer: systematic review and meta-analysis of observational studies

Components of metabolic syndrome and risk of breast cancer by prognostic features in the study of osteoporotic fractures cohort

Hematologic malignancies: an opportunity to fill a gap in cancer surveillance

Allergies and risk of head and neck cancer

Folic acid supplementation, MTHFR and MTRR polymorphisms, and the risk of childhood leukemia: the ESCALE study (SFCE)

Incidence trends in head and neck cancers and human papillomavirus (HPV)-associated oropharyngeal cancer in Canada, 1992–2009

Keynote webinar | Spotlight on antibody–drug conjugates in cancer